🚨News for the #Interventional_HF Space:
https://t.co/wPuIEovSkG
While the trial did not reach statistical significance on the primary endpoint, it did contain additional clinically meaningful prespecified analyses that favored Barostim, including:
Yet another fascinating conversation with a top #medtech leader and good friend of ours here at @AdvaMedUpdate, Nadim Yared of CVRx. Some great leadership and industry insights from @cvrxceo this week on the podcast ...
https://t.co/bGyTfaSQQg
Welcome to Day 1 of #MedTechCon! We can't wait to see in-person attendees in DC at the Capital Hilton. Sessions taking place in DC will also be livestreamed through our virtual platform. View the full agenda so you don’t miss any of the action: https://t.co/PqXlwG1qZB
@MedicalAlley just released a wide-ranging interview with @cvrxceo on CVRx's recent IPO, the #MCIT rule and many other topics related to medical innovation.
Listen to the excellent podcast here! https://t.co/dnUOSjyV7h
Welcome to #HFC member Dr. Amin Yehya, of @sentarahealth Advanced Heart Failure Center!!
@AminYehyaMD was a 2020 HFC / @HFSA Top PI award-winner, and is joining the Research Culture Working Group! We look forward to many great things to come!! #heartfailure#clinicaltrials
@LindenfeldJoann is a phenomenal inspirational leader. Her impact on cardiology, particularly for women, will be felt for decades. We are all lucky to benefit from her numerous contributions to our field. So well deserved !!!
HUGE congratulations to HFC Chair @LindenfeldJoann for @HFSA's Pioneer Award, given to an innovator in #HeartFailure who sets the stage for future generations! A true leader in the field, JoAnn has been an integral part of HFC projects and initiatives! #HFSA2021
Nanowear featured in The Wall Street Journal's The Future of Everything. Named as a startup to watch producing an all-in-one medical checkup via smart clothing. https://t.co/hrDC0IshJc
Phenomenal panel with @LindenfeldJoann sharing clinical data, including a gender analysis, @FudimMarat sharing his scientific expertise in this field, and Dr. Brian Howard his personal experience treating heart failure patients ! Looking forward to re-watching the video soon
The landscape of device based therapies in heart failure has seen a major shift in the last years. This is in parts due to a change in the regulatory environment. Our review covers devices for chronic HF, approved and in the pipeline:
https://t.co/CoxF9db6Gd
@JACCJournals
Couldn't agree more with @ErikPaulsen & @HenryIMiller: #MCIT is "sound public policy with bipartisan congressional support" & "would promote innovation and streamline access to critical technologies for patients with no other alternatives." https://t.co/1PFbRrehsD